Monday, 12 September 2011
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2011
(306)
-
▼
September
(20)
- Amrutanjan to start custom manufacturing
- CMC Biologics will manufacture Inspiration Biophar...
- Lonza plans Singapore listing
- Lonza will manufacture Pasteuria Bioscience's Past...
- Jubilant's $70m contract
- Warning letter for Lonza
- Albemarle is to increase prices for generic APIs b...
- Ark Therapeutics will provide manufacturing servic...
- Lonza has extended its $1.4bn offer for Arch Chemi...
- PharmaVentures has been appointed to find a buyer ...
- Evonik IPO reportedly delayed until 2012
- Oxford BioTherapeutics has licensed CMC Biologics’...
- Lonza and Fosun to establish jv
- Camlin Fine Chemicals has been renamed Camlin Fine...
- Oxford BioTherapeutics has licensed Lonza’s GS Gen...
- CMC Biologics has completed the installation of a ...
- Fareva acquires Pfizer plant
- DSM and Sinochem anti-infectives jv
- Sales grow for Siegfried
- BASF has increased prices of APIs and excipients b...
-
▼
September
(20)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment